MN2.F Mentice AB
- Market cap
- EUR 38.0M
- P/E
- -
- P/B
- 3.43x
- ROE
- -28.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is MN2.F undervalued?
Graham numberThe Graham number of Mentice AB cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Mentice AB fundamental analysis
No fundamental analysis for Mentice AB yet.
Mentice AB stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extens…
Full company profileMentice AB financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Mentice AB annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 185M | 218M | 274M | 290M | 279M | 283M |
| Gross Profit | 150M | 189M | 236M | 257M | 251M | 250M |
| Operating Income | -24.9M | -24.9M | -679K | -12.4M | -31.4M | -30.1M |
| EBITDA | - | 266K | 28.9M | 18.3M | 4.40M | -4.73M |
| Net Income | -29.2M | -30.7M | -2.82M | -18.4M | -32.3M | -34.7M |
| EPS | -1.16 | -1.18 | -0.11 | -0.71 | -1.15 | -1.23 |
| Balance Sheet | ||||||
| Total Assets | 262M | 333M | 323M | 324M | 312M | 299M |
| Total Liabilities | 125M | 170M | 164M | 180M | 174M | 175M |
| Shareholders' Equity | 137M | 163M | 159M | 144M | 138M | 124M |
| Cash & Short-term Investments | 12.7M | 47.3M | 59.1M | 53.6M | 33.4M | 61.1M |
| Cash Flow | ||||||
| Operating Cash Flow | -5.13M | 14.9M | 36.5M | 17.9M | -20.3M | 69.5M |
| Capital Expenditure | 25.9M | 13.1M | 6.99M | 16.4M | 15.5M | 9.28M |
| Free Cash Flow | -31.0M | 1.85M | 29.5M | 1.48M | -35.8M | 60.2M |
| Ratios | ||||||
| ROE | -21.3% | -18.9% | -1.8% | -12.8% | -23.4% | -28.1% |
| ROA | -11.1% | -9.2% | -0.9% | -5.7% | -10.4% | -11.6% |
| Net Profit Margin | -15.8% | -14.1% | -1.0% | -6.3% | -11.6% | -12.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Mentice AB dividends
Mentice AB has not paid dividends in the last 5 fiscal years.
Who owns Mentice AB
- Insiders 71.98%
- Institutions 10.58%
- Public & others 17.44%
- Shares outstanding 28.1M
- Free float 4.47M
Mentice AB company profile
- Company name
- Mentice AB
- Ticker
- MN2.F
- ISIN
- SE0012673291
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 129
- Fiscal year end
- December
- Address
- Odinsgatan 10, Gothenburg, Sweden, 411 03
- Phone
- 46 20 38 85 16 01
- Website
- mentice.com
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patient and Laerdal SimMan vascular medical simulator. It also provides flow model products, which include physiological flow systems, extensions and add-ons, silicone and 3D printed vessels, and flow system accessories; Ankyras, a clinical decision application; Mentice Live, a cloud-based learning center for medical technology industry and healthcare providers; Right Heart Cath app, a mobile solution for interactive real-time exploration into the right heart catheterization procedure; Vascular Twin, an anatomical replication for procedural and device adoption; research and development services; and professional support services for installation, training, and warranty services. It operates in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. Mentice AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.
Mentice AB management
8- Mr. Frans Matthieu VenkerGroup CEO & President · born 1973
- Mr. Rick van VeenChief Financial Officer
- Mr. Henrik StormChief Technical Officer and VP of R&D · born 1972
- Mr. Martin HarrisVice President of Marketing
- Ms. Catharina BergstromChief People Officer
- Mr. Edward FaltChief Strategy Officer and M&A · born 1977
- Mr. Alexander HusseinSenior Vice President of Strategic Accounts
- Dominic SteffelSenior Product Manager